Long-term follow-up after bronchoscopic lung volume reduction treatment with coils in patients with severe emphysema

Respirology

Volumn 20, Issue 2, 2015, Pages 319-326

  Hartman, Jorine E ^a   Klooster, Karin ^a   Gortzak, Kiki ^a   Ten Hacken, Nick H T ^a   Slebos, Dirk Jan ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

bronchoscopy and interventional technique; clinical respiratory medicine; coil; emphysema; long term follow up

Indexed keywords

ADULT; ARTICLE; BRONCHOSCOPIC LUNG VOLUME REDUCTION; BRONCHOSCOPIC LUNG VOLUME REDUCTION COIL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); DISEASE EXACERBATION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEMOPTYSIS; HUMAN; HUMAN TISSUE; LUNG EMPHYSEMA; LUNG FUNCTION TEST; MALE; MEDICAL DEVICE COMPLICATION; MIDDLE AGED; MINIMALLY INVASIVE PROCEDURE; MODIFIED MEDICAL RESEARCH COUNCIL SCORE; MORTALITY; OUTCOME ASSESSMENT; PATIENT SAFETY; PNEUMONIA; PNEUMOTHORAX; PRIORITY JOURNAL; RESIDUAL VOLUME; RESPIRATORY THERAPEUTIC DEVICE; RESPIRATORY TRACT DISEASE ASSESSMENT; SIX MINUTE WALK DISTANCE; ST. GEORGE RESPIRATORY QUESTIONNAIRE; THORAX RADIOGRAPHY; ADVERSE EFFECTS; AGED; BRONCHOSCOPY; CLINICAL TRIAL; DEVICES; EXERCISE TEST; LUNG VOLUME; PATHOPHYSIOLOGY; PILOT STUDY; PROCEDURES; PULMONARY EMPHYSEMA; QUESTIONNAIRE; TIME FACTOR;

AGED; BRONCHOSCOPY; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; LUNG VOLUME MEASUREMENTS; MALE; MIDDLE AGED; PILOT PROJECTS; PULMONARY EMPHYSEMA; RESIDUAL VOLUME; SURVEYS AND QUESTIONNAIRES; TIME FACTORS;

EID: 84921446232     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12435     Document Type: Article

References (26)

1. Mineshita M, Slebos DJ,. Bronchoscopic interventions for chronic obstructive pulmonary disease. Respirology 2014; 19: 1126-1137.
2. Herth FJ, Eberhardt R, Gompelmann D, Ficker JH, Wagner M, Ek L, Schmidt B, Slebos DJ,. Radiological and clinical outcomes of using Chartis to plan endobronchial valve treatment. Eur. Respir. J. 2013; 41: 302-308.
3. Shah PL, Herth FJ,. Current status of bronchoscopic lung volume reduction with endobronchial valves. Thorax 2014; 69: 280-286.
4. Slebos DJ, Klooster K, Ernst A, Herth FJ, Kerstjens HA,. Bronchoscopic lung volume reduction coil treatment of patients with severe heterogeneous emphysema. Chest 2012; 142: 574-582.
5. Shah P, Zoumot Z, Singh S, Bicknell SR, Ross ET, Quiring J, Hopkinson NS, Kemp SV, RESET Trial Study Group. Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial. Lancet Respir. Med. 2013; 1: 233-240.
6. Herth FJ, Eberhard R, Gompelmann D, Slebos DJ, Ernst A,. Bronchoscopic lung volume reduction with a dedicated coil: a clinical pilot study. Ther. Adv. Respir. Dis. 2010; 4: 225-231.
7. Deslee G, Klooster K, Hetzel M, Stanzel F, Kessler R, Marquette CH, Witt C, Blaas S, Gesierich W, Herth FJ, et al. Lung volume reduction coil treatment for patients with severe emphysema, a European multicenter feasibility trial. Thorax 2014; 69: 980-986.
8. Klooster K, ten Hacken N, Franz I, Kerstjens HA, van Rixvoort EM, Slebos DJ,. Lung volume reduction coil treatment in COPD patients with homogeneous emphysema: a prospective feasibility trial. Respiration 2014; 88: 116-125.
9. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al. Standardisation of spirometry. Eur. Respir. J. 2005; 26: 319-338.
10. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten CP, et al. Standardisation of the measurement of lung volumes. Eur. Respir. J. 2005; 26: 511-522.
11. Brooks D, Solway S, Gibbons WJ,. ATS statement on six-minute walk test. Am. J. Respir. Crit. Care Med. 2003; 167: 1287.
12. Jones PW, Quirk FH, Baveystock CM,. The St George's Respiratory Questionnaire. Respir. Med. 1991; 85 (Suppl. B): 25-31; discussion 33-7.
13. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA,. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 581-586.
14. Donohue JF,. Minimal clinically important differences in COPD lung function. COPD 2005; 2: 111-124.
15. Hartman JE, Ten Hacken NH, Klooster K, Boezen HM, de Greef MH, Slebos DJ,. The minimal important difference for residual volume in patients with severe emphysema. Eur. Respir. J. 2012; 40: 1137-1141.
16. Puhan MA, Chandra D, Mosenifar Z, Ries A, Make B, Hansel NN, Wise RA, Sciurba F, NETT Research Group. The minimal important difference of exercise tests in severe COPD. Eur. Respir. J. 2011; 37: 784-790.
17. Jones PW,. St: George's Respiratory Questionnaire. MCID. COPD 2005; 2: 75-79.
18. Lange P, Marott JL, Vestbo J, Olsen KR, Ingebrigtsen TS, Dahl M, Nordestgaard BG,. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am. J. Respir. Crit. Care Med. 2012; 186: 975-981.
19. Almagro P, Martinez-Camblor P, Soriano JB, Marin JM, Alfageme I, Casanova C, Esteban C, Soler-Cataluna JJ, de Torres JP, Celli BR, et al. Finding the best thresholds of FEV1 and dyspnea to predict 5-year survival in COPD patients: the COCOMICS study. PLoS ONE 2014; 9: e89866.
20. Naunheim KS, Wood DE, Mohsenifar Z, Sternberg AL, Criner GJ, DeCamp MM, Deschamps CC, Martinez FJ, Sciurba FC, Tonascia J, et al. Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann. Thorac. Surg. 2006; 82: 431-443.
21. Gelb AF, McKenna RJ Jr, Brenner M, Epstein JD, Zamel N,. Lung function 5 yr after lung volume reduction surgery for emphysema. Am. J. Respir. Crit. Care Med. 2001; 163: 1562-1566.
22. Travaline JM, Gaughan JP, Furukawa S, Criner GJ,. Effect of bilateral lung volume reduction surgery on FEV1 decline in severe emphysema. COPD 2005; 2: 203-208.
23. Kramer MR, Refaely Y, Maimon N, Rosengarten D, Fruchter O,. Two-year follow-up in patients treated with emphysematous lung sealant for advanced emphysema. Chest 2013; 144: 1677-1680.
24. Venuta F, Anile M, Diso D, Carillo C, De Giacomo T, Andrilli D, Fraioli F, Rendina EA, Coloni GF,. Long-term follow-up after bronchoscopic lung volume reduction in patients with emphysema. Eur. Respir. J. 2012; 39: 1084-1089.
25. Kotecha S, Westall GP, Holsworth L, Pham A, Williams TJ, Snell GI,. Long-term outcomes from bronchoscopic lung volume reduction using a bronchial prosthesis. Respirology 2011; 16: 167-173.
26. Hopkinson NS, Kemp SV, Toma TP, Hansell DM, Geddes DM, Shah PL, Polkey MI,. Atelectasis and survival after bronchoscopic lung volume reduction for COPD. Eur. Respir. J. 2011; 37: 1346-1351.